Correlation Between National CineMedia and Apogee Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both National CineMedia and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining National CineMedia and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between National CineMedia and Apogee Therapeutics, Common, you can compare the effects of market volatilities on National CineMedia and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in National CineMedia with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of National CineMedia and Apogee Therapeutics,.

Diversification Opportunities for National CineMedia and Apogee Therapeutics,

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between National and Apogee is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding National CineMedia and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and National CineMedia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on National CineMedia are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of National CineMedia i.e., National CineMedia and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between National CineMedia and Apogee Therapeutics,

Given the investment horizon of 90 days National CineMedia is expected to generate 4.73 times less return on investment than Apogee Therapeutics,. But when comparing it to its historical volatility, National CineMedia is 2.81 times less risky than Apogee Therapeutics,. It trades about 0.04 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  4,504  in Apogee Therapeutics, Common on September 21, 2024 and sell it today you would earn a total of  198.00  from holding Apogee Therapeutics, Common or generate 4.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

National CineMedia  vs.  Apogee Therapeutics, Common

 Performance 
       Timeline  
National CineMedia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days National CineMedia has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong primary indicators, National CineMedia is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
Apogee Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

National CineMedia and Apogee Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with National CineMedia and Apogee Therapeutics,

The main advantage of trading using opposite National CineMedia and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if National CineMedia position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.
The idea behind National CineMedia and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Technical Analysis
Check basic technical indicators and analysis based on most latest market data